SEARCH
= Registered usersPractitioner CPD prompts to action
Immediate CPD prompts
These templates*, associated with all articles, prompt drafting of personal learning, reflection and planning.
Save your record into your personal development folder on your device or cloud storage system.
*Adobe fillable PDFs. Adobe reader needed for iPad
Case report submission
Your case report would need to be around 1,500 words long, include a brief review of the literature to put the case in context, and be fully referenced in the Vancouver style.
Submissions for consideration should be sent to:
[email protected]
Comment or question
If you, or your peer group, would like to comment on an article or have a question for the authors, write to:
Bland P. Anticholinergic drugs and risk of dementia. Practitioner July/August 2018;262(1817):5
Anticholinergic drugs and risk of dementia
25 Jul 2018
Antidepressant, urological and anti-parkinsonian drugs with definite anticholinergic effects are associated with an increased risk of incident dementia up to 20 years after exposure, a UK nested case-control study has found. The study authors conclude: 'Clinicians should continue to be vigilant with respect to the use of anticholinergic drugs, and should consider the risk of long-term cognitive effects, as well as short-term effects, associated with specific drug classes when performing their risk-benefit analysis.'
This article can be accessed only if you are a paid-up subscriber to The Practitioner.
To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .